Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia

Journal of Lipid Research

Volumn 38, Issue 10, 1997, Pages 2071-2078

  Marais, A David ^a   Naoumova, Rossitza P ^b   Firth, Jean C ^a   Penny, Candice ^a   Neuwirth, Clare K Y ^b   Thompson, Gilbert R ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Apheresis; HMG CoA reductase; LDL receptor mutation; Mevalonic acid; Simvastatin

Indexed keywords

APOLIPOPROTEIN B; ATORVASTATIN; CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVALONIC ACID;

ADOLESCENT; ADULT; APHERESIS; ARTICLE; CLINICAL ARTICLE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HOMOZYGOTE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN SYNTHESIS; MALE; PLASMAPHERESIS; PRIORITY JOURNAL;

EID: 0030716524     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Hobbs, H. H., D. W. Russell, M. S. Brown, and J. L. Goldstein. 1990. The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu. Rev. Genet. 24: 133-710.
2. Hobbs, H. H., M. S. Brown, and J. L. Goldstein. 1992. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum. Mutat. 1: 445-466.
3. Seftel, H. C., S. G. Baker, M. P. Sandler, M. B. Forman, B. I. Joffe, D. Mendelsobn, T. Jenkins, and O. J. Mieny. 1980. A host of hypercholesterolaemic homozygotes in South Africa. Br. Med. J. 281: 633-636.
4. Thompson, G. R., R. Lowenthal, and N. B. Myant. 1975. Plasma exchange in the management of homozygous familial hypercholesterolaemia. Lancet. 1: 1208-1211.
5. Stoffel, W., H. Borberg, and V. Greve. 1981. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia. Lancet. 2: 1005-1007.
6. Thompson, G. R., J. P. Miller, and J. L. Breslow. 1985. Improved survival of patients with homozygous familial hypercholesterolaemia treated by plasma exchange. Br. Med. J. 291: 1671-1673.
7. Rallidis, L., P. Nihoyannopoulos, and G. R. Thompson. 1996. Aortic stenosis in homozygous familial hypercholesterolaemia. Heart. 76: 84-85.
8. Thompson, G. R., J. Ford, M. Jenkinson, and I. Trayner. 1986. Efficacy of mevinolin as adjuvant therapy for refractory familial hypercholesterolaemia. Q. J. Med. 60: 803-811.
9. Marais, A. D., L. Wood, J. C. Firth, J. M. Hall, and P. Jacobs. 1993. Plasma exchange for homozygous familial hypercholesterolaemia: the Cape Town experience. Transfus. Sci. 14: 239-247.
10. Bilheimer, D. W., S. M. Grundy, M. S. Brown, and J. L. Goldstein. 1983. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Proc. Natl. Acad. Sci. USA. 80: 4124-4128.
11. Naoumova, R. P., A. D. Marais, J. Mountney, J. C. Firth, N. B. Rendell, G. W. Taylor, and G. R. Thompson. 1996. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia. Atherosclerosis. 119: 203-213.
12. Rubinsztein, D. C., D. R. van der Westhuysen, and G. A. Coetzee. 1994. Monogenic primary hypercholesterolaemia in South Africa. S. Afr. Med. J. 84: 339-344.
13. Webb, J. C., X-M. Sun, S. N. McCarthy, C. Neuwirth, G. R. Thompson, B. L. Knight, and A. K. Soutar. 1996. Characterization of mutations in the low density lipoprotein (LDL)-receptor gene in patients with homozygous familial hypercholesterolemia, and frequency of these mutations in FH patients in the United Kingdom. J. Lipid Res. 37: 368-381.
14. Goldstein, J. L., and M. S. Brown. 1983. Familial hypercholesterolemia. In The Metabolic Basis of Inherited Disease. J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson, J. L. Goldstein, and M. S. Brown, editors. McGraw Hill, New York. 672-712.
15. Kitano, Y., and G. R. Thompson. 1993. Role of LDL apheresis in the management of hypercholesterolemia. Transfus. Sci. 14: 269-280.
16. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
17. Parker, T. S., D. J. McNamara, C. Brown, D. Garrigan, R. Kolb, H. Batwin, and E. H. Ahrens, Jr. 1982. Mevalonic acid in human plasma: relationship of concentration and circadian rhythm to cholesterol synthesis rates in man. Proc. Natl. Acad. Sci. USA. 79: 3037-3041.
18. Jones, P. J. H., A. S. Pappu, D. R. Illingworth, and C. A. Leitch. 1992. Correspondence between plasma mevalonic acid levels and deuterium uptake in measuring human cholesterol synthesis. Eur. J. Clin. Invest. 22: 609-613.
19. Yoshida, T., A. Houda, N. Tanaka, Y. Matsuzaki, B. He, T. Osuga, N. Kobajashi, K. Ozawa, and H. Miyazaki. 1993. Simultaneous determination of mevalonate and 7α-hydroxy-cholesterol in human plasma by gas chromatography-mass spectrometry as indices of cholesterol and bile acid biosynthesis. J. Chromatogr. 613: 185-193.
20. Pfohl, M., R. P. Naoumova, C. Klass, W. Knisel, B. Jakober, T. Risler, and G. R. Thompson. 1994. Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG-CoA reductase inhibitor therapy. J. Lipid Res. 35: 1946-1955.
21. Apstein, C. S., D. B. Zilversmit, R. S. Lees, and P. K. George. 1978. Effect of intensive plasmapheresis on the plasma cholesterol concentration with familial hypercholesterolemia. Atherosclerosis. 31: 105-115.
22. Thompson, G. R., T. Spinks, A. Ranicar, and N. B. Myant. 1977. Non-steady state studies of low-density-lipoprotein turnover in familial hypercholesterolaemia. Clin. Sci. Mol. Med. 52: 361-369.
23. Barbir, M., A. Khaghani, A. Kehely, K-C. Tan, A. Mitchell, G. R. Thompson, and M. Yacoub. 1992. Normal levels of lipoproteins including lipoprotein[a] after liver-heart transplantation in a patient with homozygous familial hypercholesterolaemia. Q. J. Med. New Series. 85: 807-812.
24. Uauy, R., G. L. Vega, S. M. Grundy, and D. M. Bilheimer. 1988. Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: lack of effect on low density lipoprotein concentrations or turnover. J. Pediatr. 113: 387-392.
25. Soutar, A. K., N. B. Myant, and G. R. Thompson. 1977. Simultaneous measurement of apolipoprotein B turnover in very low and low density lipoproteins in familial hypercholesterolemia. Atherosclerosis. 28: 247-256.
26. Fisher, W. R., L. A. Zech, and P. W. Stacpoole. 1994. ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm. Arterioscler. Thromb. 14: 501-510.
27. Bilheimer, D. W., J. L. Goldstein, S. M. Grundy, and M. S. Brown. 1975. Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in patient with homozygous familial hypercholesterolemia. J. Clin. Invest. 56: 1420-1430.
28. McNamara, D. J., E. H. Ahrens, R. Kolb, C. D. Brown, T. S. Parker, N. O. Davidson, P. Samuel, and R. M. McVie. 1983. Treatment of familial hypercholesterolemia by portacaval anastomosis: effect on cholesterol metabolism and pool size. Proc. Natl. Acad. Sci. USA. 80: 564-568.
29. Feher, M. D., J. C. Webb, D. D. Patel, A. F. Lant, P. D. Mayne, B. L. Knight, and A. K. Soutar. 1993. Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemia. Atherosclerosis. 103: 171-180.
30. Nawrocki, J. W., S. R. Weiss, M. H. Davidson, D. L. Sprecher, S. L. Schwartz, P. J. Lupien, P. H. Jones, H. E. Haber, and D. M. Black. 1995. Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler. Thromb. Vasc. Biol. 15: 678-682.
31. Naoumova, R. P., A. D. Marais, J. C. Firth, C. Neuwirth, G. W. Taylor, and G. R. Thompson. 1996. Apheresis plus atorvastatin: A hard act for gene therapy to follow? In Abstracts of the 66th Congress of the European Atherosclerosis Society, Florence, Italy, July 1996. Fondazione Giovanni Lorenzini, Milan. 24.
32. Naoumova, R. P., S. Dunn, L. Rallidis, O. Abu-Muhana, C. Neuwirth, N. B. Rendell, G. W. Taylor, and G. R. Thompson. 1997. Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin. J. Lipid Res. 38: 1496-1500.
33. Bocan, T. M. A., M. J. Mazur, S. B. Mueller, E. Q. Brown, D. R. Sliskovic, P. M. O'Brien, M. W. Creswell, H. Lee, P. D. Uhlendorf, B. D. Roth, and R. S. Newton. 1994. Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: a biochemical and morphological evaluation. Atherosclerosis. 111: 127-142.
34. Langer, T., W. Strober, and R. I. Levy. 1972. The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. J. Clin. Invest. 51: 1528-1536.
35. Levy, R. I., and T. Langer. 1972. Hypolipidemic drugs and lipoprotein metabolism. In Pharmacological Control of Lipid Metabolism. W. L. Holmes, R. Paoletti, and D. Kritchevsky, editors. Plenum Press, New York. Adv. Exp. Med. Biol. 26: 155-163.
36. Khan, B., H. G. Wilcox, and M. Heimberg. 1989. Cholesterol is required for secretion of very-low-density lipoprotein by rat liver. Biochem. J. 258: 807-816.
37. Thompson, G. R., R. P. Naoumova, and G. F. Watts. 1996. Role of cholesterol in regulating apolipoprotein B secretion by the liver. J. Lipid Res. 37: 439-447.
38. Bakker-Arkema, R. G., M. H. Davidson, R. J. Goldstein, J. Davignon, J. L. Isaacsohn, S. R. Weiss, L. M. Keilson, V. Brown, V. T. Miller, L. J. Shurzinske, and D. M. Black. 1996. Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. J. Am. Med. Assoc. 275: 128-133.
39. Burnett, J. R., L. J. Wilcox, D. E. Telford, S. J. Kleinstiver, P. H. R. Barrett, R. S. Newton, and M. W. Huff. 1996. Inhibition of apoB secretion by atorvastatin, in vivo, is correlated with decreased hepatic apoB mRNA abundance. Circulation. 94: I-632.
40. Thompson, G. R. 1996. Low-density lipoprotein apheresis and liver transplantation in the management of familial hypercholesterolaemia in childhood. In Hyperlipidaemia in Childhood. A. Neil, A. Rees, and C. Taylor, editors. Royal College of Physicians of London on behalf of the British Hyperlipidaemia Association, London. 67-75.
41. Hoeg, J. M., I. M. Feuerstein, and E. E. Tucker. 1994. Detection and quantitation of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia. Arterioscler. Thromb. 14: 1066-1074.